UK ovarian cancer rates up, survival down
This article was originally published in Clinica
Ovarian cancer rates in the UK have increased between 20 and 25% over the last 20 years, while five-year survival rates across the UK have remained at 29%, among the lowest in Europe. The figures, announced at a meeting of the British Gynaecological Cancer Society (BGCS), highlight the poor state of the UK's cancer services and the need for an effective ovarian cancer screening programme.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.